Related Experiment Video
Updated: Jun 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Advances in percutaneous coronary intervention in patients with chronic kidney disease
Walter C Coats1, Kevin C Dellsperger
1Department of Internal Medicine (Cardiovascular Medicine), University of Missouri, Columbia, Missouri 65212, USA.
Insights
Coronary artery disease is a leading cause of death in chronic kidney disease (CKD) patients. This review explores how new percutaneous coronary interventions improve outcomes for these high-risk individuals.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) is the primary cause of mortality in patients with chronic kidney disease (CKD).
- Patients with CKD and renal impairment are significantly underrepresented in left heart catheterization and coronary intervention procedures compared to those with normal renal function.
- Invasive strategies in CKD patients are associated with increased risks of bleeding and ischemic events.
Purpose of the Study:
- To review recent advancements in percutaneous coronary intervention (PCI).
- To assess the impact of these PCI advancements on patients with chronic kidney disease (CKD).
- To highlight the role of updated antiplatelet therapies and drug-eluting stents in managing CAD in CKD.
Main Methods:
- Literature review of recent studies on percutaneous coronary intervention in CKD patients.
- Analysis of data concerning antiplatelet therapy efficacy and safety in renal impairment.
- Examination of outcomes associated with drug-eluting stents in the CKD population.
Main Results:
- Advances in PCI, including novel antiplatelet agents and drug-eluting stents, offer improved safety and efficacy profiles.
- These innovations may mitigate the higher risks of bleeding and ischemic events previously observed in CKD patients undergoing PCI.
- Optimized PCI strategies are crucial for improving cardiovascular outcomes in the growing population of CKD patients with CAD.
Conclusions:
- Percutaneous coronary intervention has evolved significantly, offering better therapeutic options for patients with chronic kidney disease and coronary artery disease.
- Careful selection of antiplatelet therapy and stent type is paramount to maximizing benefits and minimizing risks in this vulnerable patient group.
- Further research is warranted to refine PCI protocols and enhance long-term outcomes for CKD patients with established coronary artery disease.
Abstract:
Coronary artery disease is the number one cause of death in patients with chronic kidney disease (CKD). However,patients with impaired renal function are much less likely than patients with normal renal function to undergo left heart catheterization and coronary intervention. Patients that do receive invasive strategies experience more bleeding and higher rates of ischemic events. In this review, we examine advances in percutaneous coronary intervention--including antiplatelet therapy and drug-eluting stents--and their impact on patients with CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization I: Pre-Procedure Overview
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care

